SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-217478
Filing Date
2023-08-22
Accepted
2023-08-22 08:00:28
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFM14A d536160ddefm14a.htm DEFM14A 1854123
2 GRAPHIC g536160dsp1a.jpg GRAPHIC 1522
3 GRAPHIC g536160dsp1b.jpg GRAPHIC 1224
4 GRAPHIC g536160dsp1c.jpg GRAPHIC 2221
5 GRAPHIC g536160dsp1d.jpg GRAPHIC 1883
6 GRAPHIC g536160dsp2.jpg GRAPHIC 1898
7 GRAPHIC g536160dspp01.jpg GRAPHIC 8613
8 GRAPHIC g536160g02a02.jpg GRAPHIC 73746
  Complete submission text file 0001193125-23-217478.txt   1981570
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-37785 | Film No.: 231190991
SIC: 2834 Pharmaceutical Preparations